Baltimore, MD, United States of America

Josiah Verkaik

This inventor holds 1 USPTO granted patent. Top assignee: Cranius LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josiah Verkaik. Retrieved from https://idiyas.com/inventor/josiah-verkaik-2541smal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Josiah Verkaik and Cranial Drug Delivery Innovation.

Introduction

Josiah Verkaik is an inventor based in Baltimore, Maryland. His patent work includes a cranial drug delivery system designed to combine reconstructive medical implants with controlled fluid delivery.

Latest Patents

Verkaik is associated with 1 patent, titled “Cranial Drug Delivery System.” The invention describes a medical implant housing that can replace missing bone or soft tissue and deliver fluid to a target site through at least one catheter. Its proposed components include a two-phase propellant, a pump intended to maintain constant infusion pressure, and a mechanical flow regulator designed to maintain a constant flow rate.

Career Highlights

Verkaik’s listed company is Cranius LLC. His patent reflects an approach that integrates reconstructive implant design with mechanisms for regulating medication delivery.

Collaborations

Verkaik’s listed coworkers include Owen Friesen and Basile Michelet. Their names are associated with his professional network.

Conclusion

Josiah Verkaik’s patent describes a reconstructive cranial implant that incorporates controlled fluid delivery, bringing together implant design and drug-delivery mechanisms.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…